首页> PloS one> Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study.

Oral mucosal lesions and risk of all-cause and cardiovascular mortality in people treated with long-term haemodialysis: The ORAL-D multinational cohort study.

导出 OA

翻译打印收藏纠错

第一作者： Marinella,Ruospo

第一单位： Diaverum Medical Scientific Office, Lund, Sweden.

作者： Marinella,Ruospo ^[1] ; Suetonia C,Palmer ^[2] ; Giusi,Graziano ^[1] ; Patrizia,Natale ^[3] ; Valeria,Saglimbene ^[4] ; Massimo,Petruzzi ^[5] ; Michele,De Benedittis ^[5] ; Jonathan C,Craig ^[6] ; David W,Johnson ^[7] ; Pauline,Ford ^[8] ; Marcello,Tonelli ^[9] ; Eduardo,Celia ^[1] ; Ruben,Gelfman ^[1] ; Miguel R,Leal ^[1] ; Marietta,Török ^[1] ; Paul,Stroumza ^[1] ; Luc,Frantzen ^[1] ; Anna,Bednarek-Skublewska ^[10] ; Jan,Dulawa ^[11] ; Domingo,Del Castillo ^[1] ; Staffan,Schön ^[1] ; Amparo G,Bernat ^[1] ; Jörgen,Hegbrant ^[1] ; Charlotta,Wollheim ^[1] ; Letizia,Gargano ^[1] ; Giovanni F M,Strippoli ^[12] ; ORAL-D Investigators

作者单位： Diaverum Medical Scientific Office, Lund, Sweden. ^[1] University of Otago, Christchurch, New Zealand. ^[2] Diaverum Medical Scientific Office, Lund, Sweden.;University of Bari, Bari, Italy. ^[3] Diaverum Medical Scientific Office, Lund, Sweden.;University of Sydney, Sydney, Australia. ^[4] University of Bari, Bari, Italy. ^[5] Flinders University, Adelaide, Australia. ^[6] University of Queensland, Brisbane, Australia.;Translational Research Institute, Brisbane, Australia. ^[7] University of Queensland, Brisbane, Australia. ^[8] University of Calgary, Calgary, Canada. ^[9] Diaverum Medical Scientific Office, Lund, Sweden.;Medical University of Lublin, Lublin, Poland. ^[10] Diaverum Medical Scientific Office, Lund, Sweden.;Medical University of Silesia, Silesia, Poland. ^[11] Diaverum Medical Scientific Office, Lund, Sweden.;University of Bari, Bari, Italy.;University of Sydney, Sydney, Australia. ^[12]